|
Feb 21
|
Repligen's Q4 Earnings Beat Estimates, Revenues In Line
|
|
Feb 21
|
Repligen Corp (RGEN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
|
|
Feb 21
|
Q4 2024 Repligen Corp Earnings Call
|
|
Feb 20
|
Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook
|
|
Feb 20
|
February 2025's US Stocks That May Be Trading Below Fair Value
|
|
Feb 20
|
Repligen (RGEN) Beats Q4 Earnings Estimates
|
|
Feb 20
|
Repligen (NASDAQ:RGEN) Posts Q4 Sales In Line With Estimates
|
|
Feb 20
|
Repligen: Q4 Earnings Snapshot
|
|
Feb 20
|
Repligen Reports Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 19
|
Earnings To Watch: Repligen (RGEN) Reports Q4 Results Tomorrow
|
|
Feb 18
|
Repligen Corporation's (NASDAQ:RGEN) Intrinsic Value Is Potentially 80% Above Its Share Price
|
|
Feb 12
|
3 Healthcare Stocks Skating on Thin Ice
|
|
Feb 11
|
Repligen to Report Fourth Quarter and Full Year 2024 Financial Results
|
|
Sep 9
|
Reasons for the Decline of Repligen (RGEN) in Q2
|
|
Sep 7
|
Repligen Corporation (RGEN) Fell Due to CEO Transition
|
|
Aug 29
|
Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound?
|
|
Aug 29
|
Repligen Corporation (NASDAQ:RGEN) Shares Could Be 23% Below Their Intrinsic Value Estimate
|
|
Jul 31
|
Repligen's (RGEN) Q2 Earnings & Revenues Meet Estimates
|
|
Jul 31
|
Q2 2024 Repligen Corp Earnings Call
|
|
Jul 30
|
Repligen (RGEN) Q2 Earnings Meet Estimates
|